Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 6Thoracic 5Lymphoid 5Plasma cell 3Other hematologic neoplasm 3Genitourinary 3CNS 3Other 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Ovarian Neoplasms 3160Uterine Cervical Neoplasms 2182Endometrial Neoplasms 1330Breast Neoplasms 816Fallopian Tube Neoplasms 807Carcinoma, Ovarian Epithelial 771Neoplasms 540Colorectal Neoplasms 437Carcinoma, Non-Small-Cell Lung 418Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 353Prostatic Neoplasms 317Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 236Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 224Head and Neck Neoplasms 221Sarcoma 218Carcinoma, Renal Cell 213Recurrence 212Colonic Neoplasms 210Papillomavirus Infections 205Triple Negative Breast Neoplasms 189Squamous Cell Carcinoma of Head and Neck 175Vaginal Neoplasms 147

Interventions

Diet, Vegan 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fasting × Gynecologic × Clear all
NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡